{"id":6519,"date":"2025-08-15T08:53:00","date_gmt":"2025-08-15T06:53:00","guid":{"rendered":"https:\/\/viva.racunalniske-novice.com\/nova-resitev-za-starostno-daljnovidnost-brez-ocal\/"},"modified":"2025-08-15T08:53:00","modified_gmt":"2025-08-15T06:53:00","slug":"nova-resitev-za-starostno-daljnovidnost-brez-ocal","status":"publish","type":"post","link":"https:\/\/viva.racunalniske-novice.com\/hr\/novo-rjesenje-za-dalekovidnost-povezanu-sa-starenjem-bez-naocala\/","title":{"rendered":"Novo rje\u0161enje za dalekovidnost povezanu sa starenjem bez nao\u010dala?"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Prezbiopija, ili dalekovidnost povezana sa starenjem, poga\u0111a gotovo sve nakon 45. godine \u017eivota, iako se mo\u017ee pojaviti i ranije. Do sada su se ljudi lije\u010dili nao\u010dalama za \u010ditanje, kontaktnim le\u0107ama ili kirur\u0161kim zahvatom. No nedavno je ameri\u010dka Uprava za hranu i lijekove (FDA) odobrila novo, neinvazivno rje\u0161enje.<br><br>Inovativne kapi za o\u010di Vizz tvrtke Lenz Therapeutics nude privremeno rje\u0161enje bez potrebe za nao\u010dalama. Kapi zapravo sadr\u017ee aceklidin koji su\u017eava zjenice i stvara takozvani efekt &quot;rupice&quot;, \u010dime se pobolj\u0161ava o\u0161trina vida. U\u010dinak se javlja za oko 30 minuta i traje do 10 sati, \u0161to je dulje od Vuity kapi (4 do 6 sati). Va\u017ena prednost Vizz kapi je \u0161to ne o\u0161te\u0107uju vid na daljinu.<br><br><strong>Klini\u010dki rezultati su obe\u0107avaju\u0107i, nuspojave su blage<\/strong><br>Odobrenje FDA temeljilo se na tri studije u koje je bilo uklju\u010deno vi\u0161e od 680 ljudi i ukupno vi\u0161e od 30 000 dana lije\u010denja. CLARITY-1 i CLARITY-2 pokazali su pobolj\u0161anje vida na blizinu, dok je CLARITY-3 pokazao dobru podno\u0161ljivost tijekom \u0161estomjese\u010dnog razdoblja. Naj\u010de\u0161\u0107e nuspojave bile su blage. Neki su ljudi prijavili nuspojave poput iritacije oka, smanjenog vida pri slabom osvjetljenju, glavobolje i crvenila.<br><br><strong>U\u010dinkovitost kod prezbiopije u ranoj fazi<\/strong><br>Ne postoje slu\u017ebene preporuke u vezi dioptrije, ali stru\u010dnjaci za o\u010di ka\u017eu da su kapi naju\u010dinkovitije u ranim fazama. U praksi to zna\u010di izme\u0111u 45. i 55. godine \u017eivota. Terapijski u\u010dinci su smanjeni pri slabom osvjetljenju zbog stalno su\u017eenih zjenica.<br><br><strong>SAD: <\/strong><strong>ja<\/strong><strong>zid kraj 2025., cijena bi mogla biti visoka<\/strong><br>Prvi uzorci kapi za o\u010di Vizz tvrtke Lenz Therapeutics bit \u0107e dostupni lije\u010dnicima u SAD-u u listopadu 2025., a o\u010dekuje se da \u0107e op\u0107a prodaja po\u010deti do kraja godine. U Europi \u0107e proizvod prodavati Th\u00e9a, ali vremenski okvir jo\u0161 nije poznat. Cijena \u0107e vjerojatno biti sli\u010dna onoj kod Vuityja, oko 93 eura mjese\u010dno.<\/p>\n<div class=\"embed-container\"><iframe src=\"https:\/\/www.youtube.com\/embed\/Dqa1grMhCqU\" frameborder=\"0\" allowfullscreen><\/iframe><\/div><br\/>","protected":false},"excerpt":{"rendered":"<p>Presbiopija ali starostna daljnovidnost prizadene skoraj vse ljudi po 45. letu, \u010deprav se lahko pojavi tudi prej. Do zdaj so si ljudje pomagali z o\u010dali za branje, le\u010dami ali operacijo. Nedavno pa je ameri\u0161ka Uprava za hrano in zdravila (FDA) odobrila novo, neinvazivno re\u0161itev. Inovativne kapljice za o\u010di Vizz podjetja Lenz Therapeutics ponujajo za\u010dasno re\u0161itev [&hellip;]<\/p>","protected":false},"author":2,"featured_media":0,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[106],"tags":[192],"class_list":["post-6519","post","type-post","status-publish","format-standard","hentry","category-digitalizacija","tag-umetna-inteligenca"],"acf":{"subtitle":"V ZDA so odobrili kapljice Vizz, ki predstavljajo inovativno re\u0161itev za starostno daljnovidnost. Uporabnikom omogo\u010dajo oster bli\u017einski vid brez o\u010dal do 10 ur, brez vpliva na vid na daljavo. V Evropi jih pri\u010dakujemo kasneje.<br \/>\r\n<br \/>\r\n","heading":"","summary":"V ZDA so odobrili kapljice Vizz, ki predstavljajo inovativno re\u0161itev za starostno daljnovidnost. Uporabnikom omogo\u010dajo oster bli\u017einski vid brez o\u010dal do 10 ur, brez vpliva na vid na daljavo. V Evropi jih pri\u010dakujemo kasneje.\r\n\r\n","thumbnail_small":"https:\/\/racunalniske-novice.com\/wp-content\/uploads\/2025\/08\/eye-6186141_1280-560x315.jpg","thumbnail_large":"https:\/\/racunalniske-novice.com\/wp-content\/uploads\/2025\/08\/eye-6186141_1280-1024x682.jpg","thumbnail_caption":"","gallery":"","video_gallery":[{"youtube_url":"https:\/\/www.youtube.com\/watch?v=Dqa1grMhCqU&amp;t=80s"}],"author":"","links":[{"title":"Vizz","url":""}],"sources":null,"skip_language":[]},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nova re\u0161itev za starostno daljnovidnost brez o\u010dal? - Ra\u010dunalni\u0161ke novice<\/title>\n<meta name=\"description\" content=\"V ZDA so odobrili kapljice Vizz, ki predstavljajo inovativno re\u0161itev za starostno daljnovidnost. Uporabnikom omogo\u010dajo oster bli\u017einski vid brez o\u010dal do 10 ur, brez vpliva na vid na daljavo. V Evropi j\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/viva.racunalniske-novice.com\/hr\/wp-json\/wp\/v2\/posts\/6519\" \/>\n<meta property=\"og:locale\" content=\"hr_HR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nova re\u0161itev za starostno daljnovidnost brez o\u010dal? - Ra\u010dunalni\u0161ke novice\" \/>\n<meta property=\"og:description\" content=\"Presbiopija ali starostna daljnovidnost prizadene skoraj vse ljudi po 45. letu, \u010deprav se lahko pojavi tudi prej. Do zdaj so si ljudje pomagali z o\u010dali za branje, le\u010dami ali operacijo. Nedavno pa je ameri\u0161ka Uprava za hrano in zdravila (FDA) odobrila novo, neinvazivno re\u0161itev. Inovativne kapljice za o\u010di Vizz podjetja Lenz Therapeutics ponujajo za\u010dasno re\u0161itev [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/viva.racunalniske-novice.com\/hr\/novo-rjesenje-za-dalekovidnost-povezanu-sa-starenjem-bez-naocala\/\" \/>\n<meta property=\"og:site_name\" content=\"Ra\u010dunalni\u0161ke novice\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-15T06:53:00+00:00\" \/>\n<meta name=\"author\" content=\"sinusiks\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Napisao\/la\" \/>\n\t<meta name=\"twitter:data1\" content=\"sinusiks\" \/>\n\t<meta name=\"twitter:label2\" content=\"Procijenjeno vrijeme \u010ditanja\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/viva.racunalniske-novice.com\/nova-resitev-za-starostno-daljnovidnost-brez-ocal\/\",\"url\":\"https:\/\/viva.racunalniske-novice.com\/nova-resitev-za-starostno-daljnovidnost-brez-ocal\/\",\"name\":\"Nova re\u0161itev za starostno daljnovidnost brez o\u010dal? - Ra\u010dunalni\u0161ke novice\",\"isPartOf\":{\"@id\":\"https:\/\/viva.racunalniske-novice.com\/en\/#website\"},\"datePublished\":\"2025-08-15T06:53:00+00:00\",\"dateModified\":\"2025-08-15T06:53:00+00:00\",\"author\":{\"@id\":\"https:\/\/viva.racunalniske-novice.com\/en\/#\/schema\/person\/afb62e36efa34516d50249517e4cdbb4\"},\"breadcrumb\":{\"@id\":\"https:\/\/viva.racunalniske-novice.com\/nova-resitev-za-starostno-daljnovidnost-brez-ocal\/#breadcrumb\"},\"inLanguage\":\"hr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/viva.racunalniske-novice.com\/nova-resitev-za-starostno-daljnovidnost-brez-ocal\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/viva.racunalniske-novice.com\/nova-resitev-za-starostno-daljnovidnost-brez-ocal\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/viva.racunalniske-novice.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nova re\u0161itev za starostno daljnovidnost brez o\u010dal?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/viva.racunalniske-novice.com\/en\/#website\",\"url\":\"https:\/\/viva.racunalniske-novice.com\/en\/\",\"name\":\"Ra\u010dunalni\u0161ke novice\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/viva.racunalniske-novice.com\/en\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"hr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/viva.racunalniske-novice.com\/en\/#\/schema\/person\/afb62e36efa34516d50249517e4cdbb4\",\"name\":\"sinusiks\",\"sameAs\":[\"https:\/\/ml.racunalniske-novice.com\"],\"url\":\"https:\/\/viva.racunalniske-novice.com\/hr\/author\/sinusiks\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nova re\u0161itev za starostno daljnovidnost brez o\u010dal? - Ra\u010dunalni\u0161ke novice","description":"V ZDA so odobrili kapljice Vizz, ki predstavljajo inovativno re\u0161itev za starostno daljnovidnost. Uporabnikom omogo\u010dajo oster bli\u017einski vid brez o\u010dal do 10 ur, brez vpliva na vid na daljavo. V Evropi j","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/viva.racunalniske-novice.com\/hr\/wp-json\/wp\/v2\/posts\/6519","og_locale":"hr_HR","og_type":"article","og_title":"Nova re\u0161itev za starostno daljnovidnost brez o\u010dal? - Ra\u010dunalni\u0161ke novice","og_description":"Presbiopija ali starostna daljnovidnost prizadene skoraj vse ljudi po 45. letu, \u010deprav se lahko pojavi tudi prej. Do zdaj so si ljudje pomagali z o\u010dali za branje, le\u010dami ali operacijo. Nedavno pa je ameri\u0161ka Uprava za hrano in zdravila (FDA) odobrila novo, neinvazivno re\u0161itev. Inovativne kapljice za o\u010di Vizz podjetja Lenz Therapeutics ponujajo za\u010dasno re\u0161itev [&hellip;]","og_url":"https:\/\/viva.racunalniske-novice.com\/hr\/novo-rjesenje-za-dalekovidnost-povezanu-sa-starenjem-bez-naocala\/","og_site_name":"Ra\u010dunalni\u0161ke novice","article_published_time":"2025-08-15T06:53:00+00:00","author":"sinusiks","twitter_card":"summary_large_image","twitter_misc":{"Napisao\/la":"sinusiks","Procijenjeno vrijeme \u010ditanja":"2 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/viva.racunalniske-novice.com\/nova-resitev-za-starostno-daljnovidnost-brez-ocal\/","url":"https:\/\/viva.racunalniske-novice.com\/nova-resitev-za-starostno-daljnovidnost-brez-ocal\/","name":"Nova re\u0161itev za starostno daljnovidnost brez o\u010dal? - Ra\u010dunalni\u0161ke novice","isPartOf":{"@id":"https:\/\/viva.racunalniske-novice.com\/en\/#website"},"datePublished":"2025-08-15T06:53:00+00:00","dateModified":"2025-08-15T06:53:00+00:00","author":{"@id":"https:\/\/viva.racunalniske-novice.com\/en\/#\/schema\/person\/afb62e36efa34516d50249517e4cdbb4"},"breadcrumb":{"@id":"https:\/\/viva.racunalniske-novice.com\/nova-resitev-za-starostno-daljnovidnost-brez-ocal\/#breadcrumb"},"inLanguage":"hr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/viva.racunalniske-novice.com\/nova-resitev-za-starostno-daljnovidnost-brez-ocal\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/viva.racunalniske-novice.com\/nova-resitev-za-starostno-daljnovidnost-brez-ocal\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/viva.racunalniske-novice.com\/en\/"},{"@type":"ListItem","position":2,"name":"Nova re\u0161itev za starostno daljnovidnost brez o\u010dal?"}]},{"@type":"WebSite","@id":"https:\/\/viva.racunalniske-novice.com\/en\/#website","url":"https:\/\/viva.racunalniske-novice.com\/en\/","name":"Ra\u010dunalni\u0161ke novice","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/viva.racunalniske-novice.com\/en\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"hr"},{"@type":"Person","@id":"https:\/\/viva.racunalniske-novice.com\/en\/#\/schema\/person\/afb62e36efa34516d50249517e4cdbb4","name":"sinusiks","sameAs":["https:\/\/ml.racunalniske-novice.com"],"url":"https:\/\/viva.racunalniske-novice.com\/hr\/author\/sinusiks\/"}]}},"_links":{"self":[{"href":"https:\/\/viva.racunalniske-novice.com\/hr\/wp-json\/wp\/v2\/posts\/6519","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/viva.racunalniske-novice.com\/hr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/viva.racunalniske-novice.com\/hr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/viva.racunalniske-novice.com\/hr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/viva.racunalniske-novice.com\/hr\/wp-json\/wp\/v2\/comments?post=6519"}],"version-history":[{"count":0,"href":"https:\/\/viva.racunalniske-novice.com\/hr\/wp-json\/wp\/v2\/posts\/6519\/revisions"}],"wp:attachment":[{"href":"https:\/\/viva.racunalniske-novice.com\/hr\/wp-json\/wp\/v2\/media?parent=6519"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/viva.racunalniske-novice.com\/hr\/wp-json\/wp\/v2\/categories?post=6519"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/viva.racunalniske-novice.com\/hr\/wp-json\/wp\/v2\/tags?post=6519"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}